SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-220403
Filing Date
2020-08-14
Accepted
2020-08-14 16:26:18
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d936753d10q.htm 10-Q 716521
2 EX-31.1 d936753dex311.htm EX-31.1 6359
3 EX-31.2 d936753dex312.htm EX-31.2 6326
4 EX-32.1 d936753dex321.htm EX-32.1 6689
  Complete submission text file 0001193125-20-220403.txt   4342356

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20200630.xml EX-101.INS 944582
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20200630.xsd EX-101.SCH 39677
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20200630_cal.xml EX-101.CAL 33593
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20200630_def.xml EX-101.DEF 153312
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20200630_lab.xml EX-101.LAB 340508
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20200630_pre.xml EX-101.PRE 266580
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 201105512
SIC: 2834 Pharmaceutical Preparations